Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

2018399 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT02296203.

Good health and well-being

Published in: JAMA Oncology

Volume 5, Issue 3, pp. 343-343

Field-Weighted Citation Impact: 11.99